Dr. Luis Antonio Martinez-Velazquez, MD, PhD

Dr. Martinez-Velazquez practices at Retina Consultants in Manchester, Connecticut.

Dr. Martinez-Velazquez's NPI, 1164985933, was assigned on April 9, 2019. Dr. Martinez-Velazquez holds Massachusetts license 1014693.

Dr. Martinez-Velazquez's primary practice is Retina Consultants, at 191 Main St, Manchester, CT 06042 in Capitol County. The practice phone is (860) 646-7704.

Dr. Martinez-Velazquez's primary practice is Retina Consultants in Manchester, Connecticut. Dr. Martinez-Velazquez is also affiliated with Hartford Hospital. The medical group on file is Connecticut Children's. Dmand AI also links Dr. Martinez-Velazquez to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martinez-Velazquez practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Martinez-Velazquez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Martinez-Velazquez is licensed in Massachusetts.

CMS data shows 255 Medicare services from Dr. Martinez-Velazquez across 10 procedure codes in 2024, for 211 Medicare patients. Medicare paid $23,555 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Dr. Martinez-Velazquez in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Martinez-Velazquez's median patient age at 70, with 45% women.

In 2024, Dr. Martinez-Velazquez wrote 827 Medicare Part D claims for 303 patients. 68% of them were for generic drugs. CMS names the drug for 729 of them, across 13 drugs with 11 or more claims each, at $20,753 in total drug cost. In 2023, CMS named 308 claims across 9 drugs.

Dr. Martinez-Velazquez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Martinez-Velazquez, published from 2012 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Caenorhabditis elegans, Caenorhabditis elegans Proteins and Carbon Dioxide. Dr. Martinez-Velazquez's most frequent co-authors are Paul Shichao Zhou, Anthony A. Amato, MD and Jason Comander, MD, PhD.

CMS Open Payments shows 17 general payments to Dr. Martinez-Velazquez from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $580.